Goodwin

Contact
Share
Info
100 Northern Avenue
Boston, MA 02210, United States
Phone: 617.570.1000
Fax: 617.523.1231
Areas of Practice
  • Antitrust & Trade Regulation
  • Appellate Practice
  • Art, Entertainment, & Sports Law
  • Class Action
  • Criminal Law
  • Energy & Utilities
  • Environmental Law
  • Finance & Banking
  • Government
  • Intellectual Property
  • International Law & Trade
  • Labor & Employment Law
  • Litigation
  • Privacy
  • Products Liability
  • Real Estate
  • Science, Computers, & Tech
  • Securities Law
  • Taxation
  • Toxic Torts
  • Transportation
  • Wills, Trusts, & Estate Planning
See more
Locations
Other U.S. Locations
  • California
  • D.C.
  • Massachusetts
  • New York
Other Countries
  • France
  • Germany
  • Hong Kong
  • United Kingdom
Number of Attorneys
800+ Attorneys

Evolus Announces Progress with Botox Follow-on Biologic

Last week, Evolus, Inc. announced updates to the regulatory progress of its BLA for DWP-450 (prabotulinumtoxinA), a follow-on biologic to Allergan’s Botox (onabotulinumtoxinA injection) product. Evolus reported that FDA issued…more
 /  Science, Computers, & Technology

Filgrastim, pegfilgrastim biosimilar litigation updates

Below is a rundown of some recent developments in BPCIA litigations concerning biosimilars of Neupogen® (filgrastim) and/or Neulasta® (pegfilgrastim). Amgen v. Adello (filgrastim) - As we previously reported, in March,…more
 /  Intellectual Property, Science, Computers, & Technology

Third Circuit Holds Discovery Rule Does not Apply to FDCPA Limitations Period

On May 15, 2018, the United States Court of Appeals for the Third Circuit issued an important decision regarding the statute of limitations under the Fair Debt Collection Practices Act (FDCPA), 15 U.S.C. § 1692, et seq. In…more
 /  Civil Procedure, Finance & Banking

Apotex Proposed Merger of AUS & NZ Operations

Last week, Apotex Australia, an affiliate of the Canadian-based Apotex, Inc., announced a proposed merger of their Australian and New Zealand generic pharmaceutical and over-the-counter (OTC) operations with Arrow…more
 /  Business Organizations, Mergers & Acquisitions, Science, Computers, & Technology

HHS Seeks Public Comments on Trump Administration’s Plan to Lower Drug Prices

Last week the Department of Health and Human Services (HHS) issued a request for comments on the Trump administration’s plan to lower drug prices. The HHS blueprint to lower drug prices includes improving competition by…more
 /  Health, Science, Computers, & Technology

Massachusetts Supreme Judicial Court Describes Legal Duty For University Suicide Prevention Efforts in Nguyen v. Massachusetts Institute of Technology

On May 7, 2018, the Massachusetts Supreme Judicial Court (SJC) issued its long-awaited decision in Nguyen v. Massachusetts Institute of Technology. The case involved a 25-year-old MIT graduate student, Han Nguyen, who took his…more
 /  Civil Procedure, Education

Deal Watch: Catalent Biologics and Valerius Biopharma to Collaborate on Manufacture of Specialty Biosimilar Products

Earlier this week, Catalent Pharma Solutions and Valerius Biopharma AG jointly announced their collaboration on the manufacture of Valerius’ specialty biosimilar products. According to the press release, Catalent Biologics will…more
 /  Science, Computers, & Technology

Federal Circuit Addresses Standing in Decision on Appeal from PTAB

Last week, the Federal Circuit issued a decision in Altaire Pharmaceuticals, Inc. v. Paragon Bioteck, in which the court held that Altaire had standing to appeal the PTAB’s final written decision in a post-grant review (“PGR”)…more
 /  Civil Procedure, Constitutional Law, Intellectual Property, Science, Computers, & Technology

Financial Services Weekly News - May 2018 #3

Editor's Note - In This Issue. The Consumer Financial Protection Bureau (CFPB) published its Spring 2018 rulemaking agenda; the U.S. Department of Housing and Urban Development (HUD) announced that it will seek public…more
 /  Civil Procedure, Consumer Protection, Finance & Banking, Real Estate - Residential

Sixth Circuit Affirms Dismissal of TCPA Fax Claim Against Third Parties

On May 8, 2018, the Sixth Circuit affirmed dismissal of a Telephone Consumer Protection Act (TCPA) claim against Bristol-Myers Squibb and Pfizer. As the Sixth Circuit noted at the start of its opinion in Health One Medical…more
 /  Antitrust & Trade Regulation, Communications & Media Law

President Trump’s Remarks on Lowering Drug Prices; Industry Reactions

On May 11, President Trump delivered remarks about his administration’s new plan to help lower drug prices. The President blamed “soaring drug prices” on “everyone involved in the broken system,” including “the drug makers,…more
 /  Health, Science, Computers, & Technology

FDA accepts Coherus’s resubmitted pegfilgrastim biosimilar application

As we reported earlier this month, Coherus BioSciences recently resubmitted its application for CHS-1701, a proposed biosimilar to Neulasta® (pegfilgrastim), in response to a Complete Response Letter that it received from the…more
 /  Intellectual Property, Science, Computers, & Technology

President Trump Pulls the U.S. From the Iran Nuclear Deal

The Trump administration is withdrawing the United States from the Joint Comprehensive Plan of Action (JCPOA), the nuclear deal between Iran and the U.S., China, France, Russia, the UK, Germany and the EU. Sanctions that had…more
 /  International Law & Trade

FDA Approves Hospira’s Epoetin Alfa Biosimilar

For just the tenth time since the implementation of the BPCIA, the FDA has approved a biosimilar product. Today, the FDA announced that it has approved Pfizer-subsidiary Hospira’s Retacrit™ (epoetin alfa-epbx) for the treatment…more
 /  Antitrust & Trade Regulation, Intellectual Property, Science, Computers, & Technology

FTC Obtains Preliminary Injunction Against Mortgage Relief Operation

On May 8, the Federal Trade Commission (“FTC”) announced that the U.S. District Court for the Central District of California granted its request to preliminarily enjoin affiliated California-based debt relief companies from…more
 /  Antitrust & Trade Regulation, Finance & Banking
Showing 1-15 of 2250 Results
/
View per page
Page: of 150
This profile may constitute attorney advertising. Prior results do not guarantee a similar outcome. Any correspondence with this profile holder does not constitute a client/attorney relationship. Neither the content on this profile nor transmissions between you and the profile holder through this profile are intended to provide legal or other advice or to create an attorney-client relationship.

"My best business intelligence,
in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.